1,191 material Form 8-K filings that 965 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Tortoise Energy Infrastructure Corporation entered into a distribution agreement with PINE Distributors LLC on September 22, 2026, allowing it to sell up to 2,500,000 common shares from time to time at market prices. UBS Securities LLC is a sub-placement agent under the arrangement. Because new shares would increase the share count, existing shareholders could see their ownership percentage diluted if the shares are sold.
Up to 2,500,000 common shares, $0.001 par value, may be sold through PINE Distributors LLC as agent.
UBS Securities LLC is the sub-placement agent under an agreement dated September 22, 2026.
The offering uses a shelf registration statement filed May 8, 2026, with a prospectus supplement dated September 22, 2026.
The filing does not state the price, proceeds, or timing of any sales.
On September 21, 2026, Algorhythm Holdings and Continuation Capital, Inc. agreed to terminate a July 21, 2026 settlement covering liabilities with an original principal of $1,928,014 that CCI had acquired. The settlement had required the company to issue CCI up to 5,000,000 shares of common stock, so ending it removes that potential share issuance, while the company estimates about $1,418,649 of the covered balance remains due.
Settlement agreement dated July 21, 2026 was terminated on September 21, 2026.
The company's obligation to issue up to 5,000,000 shares to CCI, until proceeds reached 120% of the Claim Amount, is terminated.
The company estimates a remaining balance of approximately $1,418,649 due under the liabilities covered by the settlement.
An updated corporate presentation was furnished as Exhibit 99.1 on September 22, 2026.
QVC Group filed a monthly operating report with the Bankruptcy Court on September 21, 2026, covering August 1-5, 2026, after its Chapter 11 plan took effect on August 6, 2026. The unaudited report shows a loss of $42.3 million on gross sales of $295.8 million for those five days, and negative net worth of $5.84 billion. The company says the figures should not be relied on for investment decisions.
Gross sales of $295.8 million for August 1-5, 2026, with a loss of $42.3 million for the period.
The report shows a cumulative loss of $104.0 million.
Cash at period end was $205.4 million, against total liabilities of $7.89 billion and negative net worth of $5.84 billion.
The report is unaudited, covers a limited period, and is not intended for investment decisions, according to the filing.
United Parks & Resorts named Kyle Miller, its Chief Parks Operations Officer, as President effective September 22, 2026, with CEO Marc Swanson remaining in his role. The company also amended its bylaws to allow the CEO and President roles to be held by separate people, and Chief Commercial Officer Christopher Finazzo said he will resign effective September 25, 2026.
Kyle Miller, 49, appointed President effective September 22, 2026; he has been Chief Parks Operations Officer since January 2023 and joined the company in 1995
Miller's pay includes a $400,000 base salary, a bonus target of 150% of salary, and a long-term incentive target of 300% of salary
Bylaws amended effective September 22, 2026 to allow separate CEO and President roles
Christopher Finazzo notified the company on September 19, 2026 of his resignation as Chief Commercial Officer, effective September 25, 2026
Houlihan Lokey stockholders approved a second amended and restated 2016 Incentive Award Plan at the September 16, 2026 annual meeting, reserving 12 million shares and reducing the automatic annual share increase from 6% to 1%. The board also elected Thomas Reichert as an independent director effective October 1, 2026, and named Prabha Sipi Bhandari Chief Legal Officer after General Counsel Christopher Crain retired.
Proposal 4 (incentive plan) passed with 161,991,591 votes for and 42,486,557 against
Thomas Reichert joins the board effective October 1, 2026, with a $120,000 restricted stock award
Prabha Sipi Bhandari appointed Chief Legal Officer and Secretary on September 16, 2026; Christopher Crain, General Counsel since 2004, became Corporate Senior Advisor
All three director nominees were elected to terms ending at the 2029 annual meeting
Parke Bancorp declared a $0.20 per share cash dividend, payable October 16, 2026, to holders of record as of October 2, 2026. The company said it expects to pay dividends quarterly, but that future dividends are subject to board approval and may be reduced or eliminated.
Dividend amount: $0.20 per share in cash
Record date: October 2, 2026; payment date: October 16, 2026
Board anticipates quarterly dividends, subject to future declaration and possible reduction or elimination
Warner Music Group said Carianne Marshall, Co-Chair and Chief Operating Officer of its subsidiary Warner Chappell Music, will step down effective September 30, 2026, and will remain employed through January 8, 2027 to provide transition and advisory services. Her separation agreement provides severance equal to eighteen months of salary, plus bonus eligibility and other payments. The filing does not indicate a change to company financial results, but it reflects a senior leadership departure and related compensation costs.
Carianne Marshall steps down as Co-Chair and COO, Warner Chappell Music, effective September 30, 2026
Marshall remains employed through January 8, 2027 for transition and advisory services
Severance equals eighteen months of salary; also includes a $116,000 lump sum and a one-time equity award with a $1,500,000 grant date value
Full separation agreement, dated September 22, 2026, will be filed with the Form 10-K for the fiscal year ending September 30, 2026
Talos Energy completed its acquisition of deepwater assets in the Gulf of America from Shell Offshore Inc. on September 22, 2026, for a final net cash price of $420 million, which includes a $42.5 million escrow deposit paid earlier. The company also assumed proportionate decommissioning obligations, must provide financial assurance of an estimated $195.5 million, and its borrowing base under the credit agreement rose to $850 million, which matters to shareholders because it changes the company's obligations and borrowing capacity.
Final net cash purchase price at closing was $420 million, including the previously escrowed $42.5 million deposit, subject to customary post-closing adjustments.
Talos holds a 50% working interest and operatorship in the Coulomb field and a 25% non-operated working interest in the BP-operated Na Kika platform and four associated fields.
Initial decommissioning security is estimated at $195.5 million, satisfied through surety bonds at closing; 50% must be provided in cash escrow starting December 31, 2032.
Borrowing base increases from $700 million to $850 million; the company expects about $49 million in letters of credit at closing. Third quarter 2026 results are due November 3, 2026.
Northern Technologies International said director Sunggyu Lee, Ph.D., notified the company on September 21, 2026, that he will not stand for re-election to its Board of Directors at the 2027 Annual Meeting of Stockholders. The company said his decision was not based on any disagreement over its operations, policies or practices. The filing contains no financial results, and the departure is routine board turnover that takes effect after the meeting scheduled for January 15, 2027.
Director Sunggyu Lee, Ph.D., notified the company on September 21, 2026 that he will not seek re-election.
The 2027 Annual Meeting of Stockholders is currently scheduled for January 15, 2027.
The company states his decision was not due to any disagreement on operations, policies or practices.
Halozyme Therapeutics completed the sale of $1,500.0 million of 1.50% Convertible Senior Notes due 2033 on September 22, 2026, including $200.0 million from the initial purchasers' option. The company received net proceeds of approximately $1,471.1 million and plans to use part of them to repurchase existing 2027 and 2028 convertible notes, which adds new debt while potentially reducing older debt.
$1,500.0 million aggregate principal of 1.50% Convertible Senior Notes due 2033 sold, including a $200.0 million option exercise
Net proceeds of approximately $1,471.1 million, with $187.5 million used to fund capped call transactions
Expected repurchases of about $217.0 million of 2027 Notes and about $435.5 million of 2028 Notes, including accrued interest
Initial conversion price of approximately $139.84 per share; interest paid semi-annually starting April 1, 2027
Rocket One Inc. said it signed a definitive membership interest purchase agreement to acquire 100% of Tracer Drone Technologies, LLC, a New Jersey provider of drone hardware, software, training, maintenance and managed services. The closing is subject to customary conditions, and the filing does not state a purchase price, so shareholders cannot yet judge the deal's financial effect.
Agreement executed September 18, 2026; announced September 22, 2026
Rocket One would acquire 100% of Tracer, which would become a wholly owned subsidiary upon closing
Closing depends on satisfaction or waiver of customary conditions; the filing gives no purchase price or financial terms
A wholly-owned subsidiary of Ares Commercial Real Estate completed the sale of a multi-building North Carolina office property to an unaffiliated buyer on September 18, 2026, for a $64 million cash price. The company had taken legal title to the property through a deed in lieu of foreclosure in 2024 and had classified it as held for sale since the first quarter of 2026, so the sale removes a held-for-sale asset from the balance sheet. The pro forma figures are illustrative only and show the property contributed modestly to reported results.
Sale completed September 18, 2026, for a cash purchase price of $64 million to an unaffiliated buyer.
Estimated cash proceeds net of transaction costs were $61.9 million, per the pro forma balance sheet as of June 30, 2026.
Pro forma net loss for the six months ended June 30, 2026 was $8.2 million, versus $5.2 million historical.
Pro forma net loss for 2025 was $804,000, versus $902,000 historical.
Quantum X Labs said co-Chief Executive Officer Amihay Hadad stepped down effective immediately on September 22, 2026, and that his decision was not due to any disagreement with the company over operations, policies or practices. Yakov Baranes, co-CEO since May 2026, was appointed sole Chief Executive Officer as of the same date. The filing does not disclose financial results or a successor for any other role.
Amihay Hadad stepped down as Co-Chief Executive Officer, effective September 22, 2026
Hadad's departure was not the result of any disagreement with the company
Yakov Baranes, co-CEO since May 2026, was named sole Chief Executive Officer effective September 22, 2026
Group 1 Automotive closed a private offering of $1.25 billion in senior notes due 2032 and 2035, with net proceeds of about $1,236.0 million. The company plans to use the proceeds, with cash on hand, to fund its pending acquisition of dealership assets and real estate from Hennessy Automobile Companies. The notes add long-term debt, and if the Hennessy deal does not close by the outside date, the 2032 notes must be redeemed at par plus interest.
Two tranches of $625.0 million each: 6.250% notes due February 1, 2032 and 6.625% notes due February 1, 2035
Net proceeds of approximately $1,236.0 million after discounts, commissions and estimated expenses
Hennessy Acquisition must close by January 6, 2027, or the 2032 notes face a special mandatory redemption at 100% of issue price plus accrued interest
Worthington Enterprises reported fiscal 2027 first-quarter results for the three months ended August 31, 2026, with net sales up 13% to $343.9 million and diluted EPS of $0.87 versus $0.70 a year earlier. Adjusted diluted EPS rose to $0.82 from $0.78, and the company declared a quarterly dividend of $0.20 per share.
Net sales rose $40.2 million, or 13%, to $343.9 million, including 6% from acquisitions and 7% from organic growth.
GAAP net earnings increased 22% to $42.6 million; adjusted net earnings rose 3% to $40.1 million.
Free cash flow increased to $54.0 million from $27.9 million, and the company repurchased 335,000 shares for $18.2 million.
Quarterly dividend of $0.20 per share is payable December 29, 2026, to holders of record on December 15, 2026.
LeonaBio disclosed that its Series A Common Warrants, issued in December 2025 in a private placement, became exercisable on September 18, 2026 and remain exercisable until October 19, 2026. If all warrants are exercised for cash, the company would receive approximately $146.2 million, but the filing warns that some may expire unexercised or be exercised on a cashless basis if the resale registration statement is not effective, which would bring in less or no cash.
Warrants cover 23,031,494 common shares at an exercise price of $6.35 per share.
Warrants became exercisable September 18, 2026 and expire to exercise after October 19, 2026.
Full cash exercise would provide approximately $146.2 million of additional capital.
Reborn Coffee received a Nasdaq notice on September 16, 2026, saying it no longer meets the minimum $2,500,000 stockholders' equity requirement for continued listing on the Nasdaq Capital Market. The company reported stockholders' equity of $735,642 in its June 30, 2026 Form 10-Q, and it must submit a plan to regain compliance by November 2, 2026. The notice has no immediate effect on the listing, but the company states there is no assurance its plan will be accepted, and a rejected plan could lead to an appeal to a Nasdaq Hearings Panel.
On September 16, 2026, Nasdaq notified the company that its reported stockholders' equity of $735,642 is below the $2,500,000 minimum under Listing Rule 5550(b)(1).
The company also does not meet Nasdaq's alternative standards for market value of listed securities or net income from continuing operations.
A plan to regain compliance is due by November 2, 2026; if accepted, Nasdaq can grant up to 180 calendar days to regain compliance.
A separate Nasdaq notice about the late June 30, 2026 Form 10-Q was closed on September 16, 2026, after the company filed the report on September 14, 2026.
On September 22, 2026, CoreWeave completed a private offering of $4.2 billion in 2.875% convertible senior notes due April 1, 2033, including $500 million from the full exercise of the initial purchasers' option. The notes are senior unsecured obligations, guaranteed by certain subsidiaries, and can be settled in cash, shares or a combination, at CoreWeave's election. For shareholders, the notes add debt and could dilute holders on conversion, with up to 52,578,540 shares issuable at the maximum conversion rate, while capped call transactions are intended to reduce that dilution.
Notes total $4.2 billion, including $500 million from the full exercise of the initial purchasers' option; they bear 2.875% interest, payable April 1 and October 1, beginning April 1, 2027.
Initial conversion price is approximately $97.85 per share, a premium of about 22.50% over the September 17, 2026 last reported sale price of $79.88.
A maximum of 52,578,540 Class A shares may be issued on full conversion, based on the maximum conversion rate of 12.5187 shares per $1,000 principal amount.
CoreWeave may redeem the notes for cash from April 5, 2030 under certain conditions; holders may require repurchase at par plus accrued interest after a fundamental change.
Associated Banc-Corp said its General Counsel and Corporate Secretary, Randall J. Erickson, will retire from that role effective October 13, 2026. He will then serve as Attorney-Advisor through January 4, 2027, under a letter agreement that keeps his base salary, retirement benefits and incentive awards in place, which is a routine executive transition.
Randall J. Erickson retires as Executive Vice President, General Counsel and Corporate Secretary effective October 13, 2026
He will serve as Attorney-Advisor, reporting to the CEO, through the Retirement Date of January 4, 2027
He keeps his current base salary and receives the full 2026 short-term incentive amount per applicable metrics
Unvested awards under the 2025-2027 and 2026-2028 LTIPP continue to vest under the 2025 Equity Incentive Plan
KB Home reported results for the quarter ended August 31, 2026. Revenues fell 20% to $1.30 billion, net income dropped to $65.3 million from $109.8 million, and diluted earnings per share were $1.05, down from $1.61. Management kept its full-year 2026 deliveries, housing revenue and margin guidance within the ranges it last gave, but the lower quarterly profit reduces earnings for shareholders.
Revenues were $1.30 billion, down 20%, and homes delivered fell 19% to 2,732.
Housing gross profit margin was 16.5%, compared to 18.2%, and homebuilding operating income was $67.1 million, compared to $131.2 million.
Net orders fell 12% to 2,604, while backlog value rose 3% to $2.05 billion.
Full-year 2026 guidance was not changed; fourth-quarter deliveries are expected at 3,000 to 3,500 homes.
ProPetro said its PROPWR unit has signed new long-term contracts to commit about 230 megawatts of power generation capacity to a subsidiary of Targa Resources Corp., a Permian Basin energy infrastructure company. With these contracts, total capacity committed under contract for PROPWR is about 510 MW, after removing previously announced oil and gas power capacity that is no longer committed.
New contracts commit about 230 MW of behind-the-meter power to a Targa subsidiary.
Total capacity committed under contract for PROPWR is now about 510 MW.
Full deployment is expected in early 2028, and the company says it may make additional megawatts available for data center deployments in 2027 and beyond.
Domo, Inc. completed the sale of substantially all of its assets and employees to Progress Software Corporation on September 22, 2026, and received approximately $221.0 million in cash. The company renamed itself Huckleberry.ai, Inc., repaid its credit facility in full, and says it is now debt-free while retaining more than $900 million in net operating loss carryforwards.
Received approximately $221.0 million in cash at closing on September 22, 2026, or about $4.46 per share according to the press release.
Loan and Security Agreement dated August 8, 2023 terminated; all borrowings and accrued interest and fees paid in full.
Warrants issued in February 2024 and August 2024 repurchased for approximately $10.0 million in aggregate.
Common stock to trade as HUCK on the Nasdaq Global Market effective September 24, 2026, replacing the DOMO symbol; Josh James continues as CEO.
Progress Software completed its purchase of substantially all assets and certain assumed liabilities of Domo's AI and data platform business on September 22, 2026, under an agreement dated July 22, 2026. Progress paid $400 million in cash, funded from cash on hand and an existing revolving credit facility. The filing does not give the deal's financial impact, which Progress says it will discuss on its third-quarter earnings call, and financial statements will follow in an amendment.
Purchase price of $400 million in cash, funded by cash on hand and an existing revolving credit facility
Domo adds a customer base of over 2,400 businesses, according to the press release
Progress will address the financial impact on its third-quarter earnings call on Wednesday, September 30, 2026, at 5:00pm ET
Pro forma and financial statements for the Transaction will be filed by amendment to this 8-K
GE HealthCare appointed Pascal Desroches, Senior Executive Vice President and CFO of AT&T, as a director effective January 4, 2027, and to its Audit Committee and Talent, Culture, and Compensation Committee. The filing says he plans to retire from AT&T on December 31, 2026, and that the appointment adds finance and governance experience to the board.
Pascal Desroches joins the GE HealthCare Board effective January 4, 2027.
He will serve on the Audit Committee and the Talent, Culture, and Compensation Committee.
Desroches has served as CFO of AT&T since 2021 and plans to retire from AT&T on December 31, 2026.
He will receive non-employee director compensation and enter into an indemnification agreement with the company.
Tenet Healthcare issued $2 billion of 6.250% senior notes due 2034 on September 22, 2026. The company plans to use the net proceeds, with cash on hand, to redeem its $1.5 billion of 5.125% secured notes due 2027 and partly redeem $0.5 billion of its 6.125% notes due 2028. The deal refinances existing debt, and the filing does not state a change in total debt outstanding.
Issued $2,000,000,000 of 6.250% senior notes due 2034 on September 22, 2026
Proceeds, with cash on hand, to fund redemption of all $1.5 billion of 5.125% senior secured first lien notes due November 2027
Partial redemption of $0.5 billion of 6.125% senior notes due October 2028
Notes are redeemable at a make-whole premium before September 15, 2029, and at set redemption prices after that date
Agree Limited Partnership, a subsidiary of Agree Realty Corporation, completed a $400 million underwritten offering of 5.650% notes maturing October 15, 2036, with the parent and certain subsidiaries guaranteeing the debt. The offering closed September 22, 2026 with net proceeds of approximately $390.1 million after the underwriting discount and estimated expenses, adding to the company's debt load.
Notes: $400 million principal, 5.650% interest, maturing October 15, 2036
Underwriters paid 97.847% of principal; offering closed September 22, 2026
Estimated net proceeds to the issuer of approximately $390.1 million
Indenture includes limits on additional indebtedness and a requirement to maintain unencumbered assets
Wynn Resorts' subsidiaries issued $900 million of 6.875% senior notes maturing March 15, 2035, under an indenture dated September 22, 2026. Net proceeds, with cash on hand, will redeem the 5.250% senior notes due 2027 of Wynn Las Vegas, LLC, and pay issuance fees and expenses. The filing describes new debt replacing a smaller existing obligation, with covenants limiting sale-leasebacks, liens and mergers.
Notes: $900 million aggregate principal, 6.875%, maturing March 15, 2035
Proceeds plus cash on hand to redeem in full the 5.250% senior notes due 2027 of Wynn Las Vegas, LLC
Interest paid semi-annually on March 15 and September 15, starting March 15, 2027
Change of control repurchase price is 101% of principal plus accrued interest
Helmerich & Payne's board ratified pay increases for CEO Trey Adams and CFO Todd Scruggs, effective October 1, 2026. Adams' base salary rises to $1,000,000 and Scruggs' to $570,000, with higher target bonus and equity award levels for fiscal 2027. The changes raise executive pay costs, but the filing discloses no financial results or performance effects.
CEO Trey Adams' base salary increases to $1,000,000 effective October 1, 2026
Adams' target bonus rises to 130% of base salary and target long-term equity award to 500% of base salary for fiscal 2027
CFO Todd Scruggs' base salary increases to $570,000 effective October 1, 2026, with target bonus at 100% of base salary for fiscal 2027
Board ratified the changes on September 16, 2026, based on Human Resources Committee approval
On September 16, 2026, SCWorx closed a private placement of 350,000 shares of common stock, each sold with a warrant, to ten accredited investors at $2.68 per share and warrant, for gross proceeds of $938,000 before offering expenses. The filing says the company's shares are not currently trading on The Nasdaq Capital Market, and if trading does not resume by October 31, 2026, purchasers can require the company to return their subscription amounts, which would reverse the sale.
350,000 shares and 350,000 warrants sold at $2.68 per share and accompanying warrant; gross proceeds $938,000; closed September 16, 2026.
Warrants have an exercise price of $2.56 per share, are exercisable immediately and expire on the fifth anniversary of the initial exercise date.
Placement agent Dawson James Securities receives 49,860 fee shares and a cash fee of 5.0% of gross proceeds, plus expenses up to $50,000.
Purchasers may require cash repayment of their subscription amounts if the stock does not resume trading on Nasdaq by October 31, 2026.
Waterstone Financial, Inc. (NASDAQ: WSBF) said its Board declared a regular quarterly cash dividend of $0.17 per common share on September 22, 2026. The filing is a routine dividend announcement that includes no results, guidance, or other financial measures.
Heritage Global Inc. entered into a $10.0 million revolving line of credit with C3bank, National Association, on September 16, 2026, maturing January 16, 2028. The facility is secured by company and subsidiary assets and a pledge of subsidiary equity, and carries restrictions on additional borrowing and asset encumbrance.
Revolving line of credit of $10.0 million with C3bank, National Association, dated September 16, 2026
Maturity date of January 16, 2028; interest at prime rate plus 1.00%, with a floor of 7.500% per annum
Secured by company and subsidiary assets and a pledge of subsidiary equity; proceeds limited to business operations
Full agreements to be filed as exhibits to the Form 10-Q for the quarter ended September 30, 2026
Old Dominion Freight Line's board elected Worthing F. Jackman as an independent director effective September 22, 2026, while director John D. Kasarda retired the same day. The filing says Dr. Kasarda's retirement was not due to any disagreement with the company on operations, policies or practices, and Mr. Jackman's pay is a pro rata share of the standard non-employee director program.
John D. Kasarda, Ph.D. retired from the Board effective September 22, 2026, with no disagreement cited on company matters.
Worthing F. Jackman, 62, was elected to the Board effective September 22, 2026, and named independent under Nasdaq rules.
Jackman joins the Governance and Nomination Committee and Talent and Compensation Committee.
Jackman's director pay is a pro rata share of a $110,000 annual cash retainer and a $172,000 annual restricted stock award.
Curtiss-Wright's Board appointed Chief Operating Officer Kevin M. Rayment as President and Chief Executive Officer, effective January 1, 2027, and as a Board member at that time. Lynn M. Bamford, CEO since January 2021, will retire as CEO and become Executive Chair on the same date. The filing describes a planned succession, and Rayment's base salary and incentive targets are set out in the filing.
Kevin M. Rayment, age 57, joined the company in 2004 and has served as COO since April 2021 and as Executive Vice President since January 2026.
Rayment's annual base salary will be $1,100,000, with an annual target bonus of 125% of base salary.
Rayment's 2027 long-term incentive award has a target value of $5,225,000, split 30% restricted stock units, 30% performance units and 40% performance share units.
Bamford joined the company over 22 years ago and has been Chair since May 2022.
Capitol Federal Financial, Inc. disclosed that Tara Van Houweling, a reporting director and principal accounting officer, intends to leave the company effective October 9, 2026, after 23 years of service. CFO Kent Townsend will take over the principal accounting officer role, so the accounting function remains under a senior finance executive during the transition.
Tara Van Houweling notified the company of her departure on September 18, 2026, effective October 9, 2026.
Van Houweling held the roles of reporting director and principal accounting officer and had 23 years of service.
Kent Townsend, Executive Vice President and Chief Financial Officer, will serve as principal accounting officer.
BlackBerry and Vector announced that Coretura, the software-defined vehicle platform company founded by Daimler Truck and Volvo Group, has selected Alloy Kore as the first design win for the jointly developed vehicle OS. The company says the win adds over $100 million to the QNX royalty backlog and is the largest design win in QNX history, though backlog is an estimate and may not reflect actual future revenue.
Coretura selected Alloy Kore, the foundational software layer jointly developed by QNX and Vector, as the first design win for the product.
The design win adds over $100 million to the QNX royalty backlog, which the company describes as estimated future revenue from variable forecasted royalties.
The filing says the win is the largest design win in QNX history and warns that actual revenue depends on production volumes and possible contract changes or terminations.
The announcement is dated September 22, 2026, and the press release is furnished as Exhibit 99.1.
Piper Sandler Companies elected Wendy L. Schoppert as a director effective September 22, 2026, increasing the board from 10 to 11 members. She was also appointed to the Audit Committee, and her director pay includes a $100,000 pro-rated annual cash retainer and equity grants for the rest of fiscal 2026.
Schoppert, a former CFO of Sleep Number Corporation, will serve an initial term expiring at the 2027 annual shareholder meeting
Board size rose from 10 to 11 directors; she joins the Audit Committee
Director compensation: pro-rated $100,000 annual cash retainer, $60,000 initial equity grant, and pro-rated $150,000 annual equity grant
Effective September 21, 2026, Jamaal T. Lesane became Executive Vice President and Chief Legal Officer of Madison Square Garden Sports Corp. and stopped serving as Chief Operating Officer. Bryan Warner, Senior Vice President and Head of Legal, ceased to be an executive officer on the same date but remains employed with the same title under his existing employment agreement. The filing describes changes in the company's senior legal and operating leadership, with no financial figures disclosed.
Jamaal T. Lesane became Executive Vice President and Chief Legal Officer effective September 21, 2026
Lesane ceased to serve as Chief Operating Officer as of the same date
Bryan Warner ceased to be an executive officer effective September 21, 2026 but keeps his Senior Vice President, Head of Legal title
The filing is dated September 22, 2026 and was signed by Mark C. Cresitello, Senior Vice President, Deputy General Counsel and Secretary
Upbound Group said Scott Young joined as Executive Vice President and Chief Operating Officer effective September 22, 2026, reporting to CEO Fahmi Karam. The company said the newly created role will lead strategic alignment across Acima, Brigit and Rent-A-Center, and it also named Dev Chakraborty Senior Vice President and Head of Brigit.
Scott Young's offer letter sets an annual base salary of $610,000 and a cash bonus target of 60% of base salary.
Young receives a one-time sign-on award of Performance Stock Units valued at $3,111,000, earned based on stock price hurdles over four years.
Starting February 2027, Young is eligible for a long-term incentive target of 170% of base salary.
Dev Chakraborty, formerly General Manager at MoneyLion, was named SVP and Head of Brigit; the company cited Brigit at approximately $300 million in annual recurring revenue and 1.8 million paying users.
Columbus McKinnon amended its credit agreement on September 21, 2026, refinancing its $1,452.9 million Term Loan B and reducing the interest rate margin on both the term loan and its $500 million revolver by 0.50% per annum. The company expects the change to cut annual cash interest expense by at least $7.3 million, which would give shareholders a modest boost to cash flow, though the filing contains no new earnings figures.
Term Loan B refinanced in an aggregate principal amount of $1,452.9 million, with margin reduced by 0.50% per annum
Revolving Facility margin also reduced by 0.50%; dollar term SOFR margin now ranges from 1.75% to 2.75% based on leverage
Company expects annual cash interest expense to fall by at least $7.3 million; maturity dates unchanged
Amendment signed September 21, 2026 and announced in a September 22, 2026 press release
Idaho Copper received a U.S. Forest Service letter approving its Exploration Plan of Operations and 2026 annual operating plan for the CuMo project in Boise County, Idaho, clearing the way for drilling and road-building. The company says the approval removes the remaining administrative conditions and lets it start work, with up to 15,000 feet of diamond core drilling targeted this season.
Forest Service letter approving the Exploration Plan of Operations and 2026 annual operating plan; USFS accepted the company's reclamation surety bond on or before the letter date
USFS accepted the signed Forest Service Evaluation form on September 9, 2026
Company is targeting up to 15,000 feet of additional diamond core drilling this season, with a larger campaign planned for 2027 toward a Prefeasibility Study
Compass Therapeutics said the FDA recommended it conduct a trial demonstrating a survival benefit before submitting a Biologics License Application for tovecimig in previously treated advanced biliary tract cancer. The company said it does not believe a new trial is warranted before submission and will keep engaging with the FDA, which means the timing and path to approval are now uncertain.
FDA recommended a trial demonstrating a survival benefit before a BLA submission for tovecimig
Phase 2/3 COMPANION-002 showed ORR of 18.0% vs. 5.3% with paclitaxel alone (p=0.0228)
Median progression-free survival was 4.7 vs. 2.6 months, hazard ratio 0.44 (p<0.0001)
Overall survival analyses did not reach statistical significance due to crossover
GE Aerospace's independent directors appointed Wesley Bush as independent Lead Director effective September 21, 2026, succeeding Tom Horton, who remains on the Board. The Board also appointed director Judson Althoff to the Audit Committee effective the same date. The changes are governance updates with no financial figures disclosed.
Wesley Bush appointed independent Lead Director effective September 21, 2026
Tom Horton, Lead Director since 2018, remains a Board member
Judson Althoff appointed to the Audit Committee effective September 21, 2026, after joining the Board effective June 24, 2026
SCYNEXIS said its board appointed Steven K. Burke, M.D., as a director effective September 18, 2026, and named him to the Nominating and Corporate Governance Committee. Dr. Burke has more than 30 years of biopharmaceutical experience and most recently served at Akebia Therapeutics as Senior Vice President, Chief Research and Development Officer and Chief Medical Officer. The company says his kidney disease drug development expertise supports its SCY-770 program for ADPKD.
Board appointment effective September 18, 2026; Dr. Burke serves until the 2027 Annual Meeting of Stockholders.
Non-employee director pay includes a $45,000 annual retainer and a $5,000 annual retainer for committee service.
Initial grants of options and restricted stock units each cover 5,750 shares; the option exercise price is $4.46, the September 18, 2026 closing price.
The company issued a press release on September 22, 2026, furnished as Exhibit 99.1.
The FDA has lifted the full clinical hold on Filana Therapeutics' IND for a planned Phase 2a study of simufilam in TSC-related epilepsy. Patient screening is expected to begin by the first quarter of 2027, so the hold removal is a development milestone rather than a change in financial results.
FDA lifted the full clinical hold on the simufilam IND, announced September 22, 2026
Planned Phase 2a study: 16-week randomized, double-blind trial at 13 U.S. sites, targeting 40 subjects aged 12 to 55
Patient screening expected to begin by the first quarter of 2027
Company completed trial-readiness work during the hold, including engaging a clinical research organization and identifying sites
Contango Silver & Gold said on September 22, 2026 that it completed a Technical Report Summary on its Kitsault Valley Project, with an effective date of September 11, 2026, under SEC mining property disclosure rules. The company also made a new corporate presentation available the same day. The filing states that no measured mineral resources or mineral reserves are reported for the project, and that the estimate supports continued evaluation rather than a mine development decision.
Technical Report Summary dated September 21, 2026, with a mineral resource effective date of September 11, 2026
No measured mineral resources or mineral reserves are reported for the Kitsault Valley Project
The company states the estimate does not establish a mine development decision
Qualified Person Dave Larimer, CPG, Vice President Exploration, signed the report on September 18, 2026
Fiserv's Chief Administrative Officer and Chief Legal Officer, Adam L. Rosman, resigned on September 16, 2026, effective September 30, 2026. General Counsel and Secretary Eric C. Nelson will succeed him as Chief Legal Officer on October 1, 2026. The filing does not describe the reason for the departure or any financial effect.
Adam L. Rosman resigned as Chief Administrative Officer and Chief Legal Officer on September 16, 2026, effective September 30, 2026
Eric C. Nelson, current General Counsel and Secretary, becomes Chief Legal Officer on October 1, 2026
The filing does not state a reason for the resignation or name a successor for the Chief Administrative Officer role
Knightscope said it had about $27 million in estimated renewals, bookings and client awards from May 20 through September 18, 2026, across 109 contracts and awards. The company says this is an operating metric, not revenue or a GAAP measure, and that the figures are preliminary and unaudited. It is not providing or updating financial guidance, so the update does not show what the period means for results.
Total of about $27 million covers 109 contracts and awards from May 20 through September 18, 2026.
Renewals are estimated at about $19.6 million (72%) and new business at about $7.5 million (28%).
Largest renewal is a three-year master services agreement with a multinational industrial client, estimated at about $17 million over the initial term, with no minimum purchase obligation.
The company states the metric is not a measure of revenue or backlog and is not providing or updating financial guidance.
On September 21, 2026, Group 1 Automotive entered a stockholder agreement with Conifer, a fund manager the filing describes as one of its largest shareholders. The board will grow from ten to eleven members and appoint Conifer analyst Benjamin Hart effective November 1, 2026. The agreement also sets voting commitments and a 19% ownership cap on Conifer, which give shareholders a clearer view of how the company's largest holder will act.
Board expands from 10 to 11 members; Benjamin Hart, an analyst at Conifer Management, joins effective November 1, 2026.
During the Support Period, Conifer agrees to vote its shares with the board's recommendations, except on Extraordinary Transactions.
Conifer is subject to standstill limits, including no acquisition of more than 19% of outstanding common stock or voting securities.
The agreement terminates 30 days before the deadline for 2030 annual meeting nomination notices, subject to automatic extension in certain cases.
Celldex reported positive topline results from its two Phase 3 EMBARQ-CSU trials of barzolvolimab in chronic spontaneous urticaria, with both trials meeting the primary endpoint and all key secondary endpoints at Week 12. The company plans to submit a Biologics License Application to the FDA in 2027, and treatment in both trials will continue to 52 weeks. The filing contains no financial results, so the near-term effect on shareholders depends on the regulatory timeline.
EMBARQ-CSU1 and EMBARQ-CSU2 both met the primary endpoint (mean change in UAS7 at Week 12) and all key secondary endpoints across both dose groups.
Complete response (UAS7=0) at Week 12 was 42.1% to 45.7% on barzolvolimab versus 9.3% to 12.6% on placebo.
1,939 patients were randomized; data cutoff was September 9, 2026.
Viking Therapeutics reported positive topline results from the maintenance phase of its VK2735 study, in which patients moved to every-other-week or monthly dosing maintained up to 97% and up to 90% of their weight loss, respectively. The company also reported GI-related adverse event rates similar to placebo, and the filing presents no financial measures for the period.
Every-other-week dosing maintained up to 97% of Week 21 weight loss versus 61% for placebo (p<0.0001).
Monthly dosing maintained up to 90% of Week 21 weight loss versus 61% for placebo (p=0.0002).
Induction phase: weight loss of approximately 16% to 19% after 21 weeks of weekly dosing versus approximately 0% for placebo.
Management conference call scheduled for 8:00 a.m. ET on September 22, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.